Shots:

• Immunai acquires the Dropprint Genomics and also expand its team with the hiring of new experts in immunology- single-cell technologies and machine learning
• The acquisition and the new hiring will advance the Immunai’s work in single cell functional genomics to support discovery- prioritization- and development of new therapies and drug combinations
• The acquisition happened a month after Immunai raised $60M in a Series A financing round and has raised $80M in funding to date

 ­ Ref: Web Wire | Image: 10x Genomics